KaloBios Provides Update on Pipeline of Clinical Programs – Wall Street Journal (press release)
KaloBios Provides Update on Pipeline of Clinical ProgramsWall Street Journal (press release)KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-th…